← Back to Search

Coffee for Postoperative Nausea

N/A
Waitlist Available
Led By Brandon Ballhaus, BSN, RN
Research Sponsored by TriHealth Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 hours
Awards & highlights

Study Summary

This trial will test whether giving coffee to coffee-drinking patients after surgery can help shorten their stay in the post-op care unit.

Eligible Conditions
  • Post Anesthesia Care Unit Length of Stay
  • Postoperative Nausea
  • Postoperative Vomiting
  • Patient Satisfaction

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
PACU length of stay

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Patients receiving coffee postoperativelyExperimental Treatment1 Intervention
Patients who self-identify as coffee drinkers and receive coffee postoperatively
Group II: Patients not receiving coffee postoperativelyActive Control1 Intervention
Patients who self-identify as coffee drinkers and do not receive coffee postoperatively
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Coffee
2010
Completed Phase 3
~920

Find a Location

Who is running the clinical trial?

TriHealth Inc.Lead Sponsor
95 Previous Clinical Trials
50,800 Total Patients Enrolled
Brandon Ballhaus, BSN, RNPrincipal InvestigatorTriHealth Inc.

Media Library

Coffee Clinical Trial Eligibility Overview. Trial Name: NCT03712891 — N/A
Postoperative Nausea Research Study Groups: Patients not receiving coffee postoperatively, Patients receiving coffee postoperatively
Postoperative Nausea Clinical Trial 2023: Coffee Highlights & Side Effects. Trial Name: NCT03712891 — N/A
Coffee 2023 Treatment Timeline for Medical Study. Trial Name: NCT03712891 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the patient cohort size for this research endeavor?

"Affirmative. Clinicaltrials.gov records show that the trial, which was first made public on October 25th 2018, is still recruiting participants. 300 people are necessary to complete this research at one medical centre."

Answered by AI

Is there a current opportunity to apply for this research?

"Clinicaltrials.gov states that this medical study, which was initially published on October 25th 2018, is presently looking for participants. The most recent changes to the trial were made on August 18th 2022."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Evaluation of Providing Coffee to Patients Postoperatively to Decrease Length of Stay in the PACU
Rachel Baker 2018. "Evaluation of Providing Coffee to Patients Postoperatively to Decrease Length of Stay in the PACU". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03712891.
~26 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top